During the last session, Crescent Biopharma Inc (NASDAQ:CBIO)’s traded shares were 0.34 million, with the beta value of the company hitting 1.52. At the end of the trading day, the stock’s price was $12.96, reflecting an intraday loss of -4.00% or -$0.54. The 52-week high for the CBIO share is $63.00, that puts it down -386.11 from that peak though still a striking 14.66% gain since the share price plummeted to a 52-week low of $11.06. The company’s market capitalization is $8.36M, and the average intraday trading volume over the past 10 days was 0.14 million shares, and the average trade volume was 43.44K shares over the past three months.
Crescent Biopharma Inc (CBIO) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 1.00. CBIO has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
Crescent Biopharma Inc (NASDAQ:CBIO) trade information
Crescent Biopharma Inc (CBIO) registered a -4.00% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.00% in intraday trading to $12.96, hitting a weekly high. The stock’s 5-day price performance is -18.44%, and it has moved by -23.94% in 30 days. Based on these gigs, the overall price performance for the year is -47.95%.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 15.18%. While earnings are projected to return 92.98% in 2025, the next five years will return 61.53% per annum.
CBIO Dividends
Crescent Biopharma Inc is due to release its next quarterly earnings on 2023-Oct-26. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Crescent Biopharma Inc (NASDAQ:CBIO)’s Major holders
Crescent Biopharma Inc insiders own 0.16% of total outstanding shares while institutional holders control 12.09%, with the float percentage being 12.10%.
Also, the Mutual Funds coming in first place with the largest holdings of Crescent Biopharma Inc (CBIO) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 19.25 shares. This amounts to just over 0.14 percent of the company’s overall shares, with a $0.25 million market value. The same data shows that the other fund manager holds slightly less at 7.31, or about 0.05% of the stock, which is worth about $94685.0.
